Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A8721 CBR-58841 CitationTarget: 3-phosphoglycerate dehydrogenaseSummary: selective inhibitor of PHGDH -
A8723 GSK180Target: Kynurenine-3-monooxygenaseSummary: inhibitor of kynurenine-3-monooxygenase (KMO) -
B6044 NCT-501Summary: Aldehyde Dehydrogenase 1A1 (ALDH1A1) inhibitor, Potent and Selective -
B6062 Manumycin ASummary: farnesyltransferase inhibitor -
B6064 Myriocin9 CitationSummary: immunosuppressant and specific serine palmitoyltransferase inhibitor -
B6067 N-(p-amylcinnamoyl) Anthranilic AcidSummary: phospholipase A2 (PLA2) inhibitor and TRP channel blocker -
B6072 GW 610Summary: antiproliferative agent -
B2117 Pioglitazone1 CitationSummary: PPAR agonist -
B1207 Zileuton sodiumSummary: 5-lipoxygenase and leukotrienes inhibitor -
B1386 MilrinoneTarget: Phosphodiesterases (PDEs)Summary: PDE-3 inhibitor

